These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20235401)

  • 1. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
    Connors AL
    Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
    [No Abstract]   [Full Text] [Related]  

  • 2. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
    Berger JT
    Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-58. PubMed ID: 20213918
    [No Abstract]   [Full Text] [Related]  

  • 5. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
    Mehta RS
    Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
    [No Abstract]   [Full Text] [Related]  

  • 6. Both sides of pharmaceutical promotion.
    Crigger NJ; Bennison LW
    Adv Nurse Pract; 2007 Jan; 15(1):61-2, 64-5, 74. PubMed ID: 19998677
    [No Abstract]   [Full Text] [Related]  

  • 7. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
    Ravindran GD
    Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 11. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 13. The details are in the field.
    Schwab AP
    Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
    [No Abstract]   [Full Text] [Related]  

  • 14. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug samples are meant for advertising.
    Thawani V
    Issues Med Ethics; 2001; 9(3):91. PubMed ID: 16334483
    [No Abstract]   [Full Text] [Related]  

  • 16. The AAMC exhibits the behavior it condemns.
    Stossel TP
    Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug detailers, professionalism, and prudence.
    Brody H
    Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325
    [No Abstract]   [Full Text] [Related]  

  • 18. The devil in the detail(ing).
    Morreim H
    Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
    [No Abstract]   [Full Text] [Related]  

  • 19. Avoiding over-deterrence in managing physicians' relationships with industry.
    Stell LK
    Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
    [No Abstract]   [Full Text] [Related]  

  • 20. Cheap trinkets, effective marketing: small gifts from drug companies to physicians.
    Brett AS
    Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.